A carregar...
PARP Inhibitors: On the Horizon of Tailored and Personalized Therapies for Epithelial Ovarian Cancer
PURPOSE OF REVIEW: Management of the epithelial ovarian cancer (EOC) remains a therapeutic challenge, with continued poor overall survival. Given low chemotherapy response rates for recurrent disease and short survival times, new treatment options with improved therapeutic indices for targeting canc...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3799945/ https://ncbi.nlm.nih.gov/pubmed/22759740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e3283564230 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|